|
TMEM9B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.383700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.452420E-01 |
| Normal-vs-Stage2 |
8.589600E-01 |
| Normal-vs-Stage3 |
1.668470E-02 |
| Normal-vs-Stage4 |
1.324560E-03 |
| Stage1-vs-Stage2 |
2.516200E-01 |
| Stage1-vs-Stage3 |
1.178420E-01 |
| Stage1-vs-Stage4 |
2.243800E-02 |
| Stage2-vs-Stage3 |
4.420100E-02 |
| Stage2-vs-Stage4 |
6.980900E-03 |
| Stage3-vs-Stage4 |
3.409000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.087700E-02 |
| Normal-vs-AfricanAmerican |
2.013200E-01 |
| Normal-vs-Asian |
6.816000E-02 |
| Caucasian-vs-AfricanAmerican |
8.914000E-01 |
| Caucasian-vs-Asian |
8.733800E-01 |
| AfricanAmerican-vs-Asian |
9.866400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.865760E-02 |
| Normal-vs-Female |
1.204800E-01 |
| Male-vs-Female |
1.346770E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.573600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.487170E-01 |
| Normal-vs-Age(61-80Yrs) |
2.120200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.865050E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.441200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.446800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.468800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.149600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.084800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.342200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.495600E-03 |
| Classical-VS-Follicular |
2.424400E-01 |
| Classical-VS-Other |
1.591640E-01 |
| Classical-VS-Normal |
8.349900E-02 |
| Tall-VS-Follicular |
2.956700E-03 |
| Tall-VS-Other |
7.115000E-01 |
| Tall-VS-Normal |
9.807900E-04 |
| Follicular-VS-Other |
1.682570E-01 |
| Follicular-VS-Normal |
6.948800E-01 |
| Other-VS-Normal |
3.648200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.150640E-01 |
| Normal-vs-N1 |
2.239300E-04 |
| N0-vs-N1 |
6.642900E-03 |
|
|
